Researcher
Steven Joniau
- Disciplines:Urology and nephrology
Affiliations
- Urogenital, Abdominal and Plastic Surgery (Division)
Member
From1 Jan 2019 → Today - Woman and Child (Division)
Member
From1 Apr 2013 → 31 Dec 2018
Projects
1 - 10 of 12 results
- Classical and non-classical actions of androgens and their receptorFrom1 Oct 2019 → TodayFunding: BOF - projects, IOF - technology concept exploration
- Fellowship: Optimization patient treatment pathway by combining genotypic and phenotypic data.From17 Dec 2018 → 16 Dec 2019Funding: Private funding of national origin - undefined
- Novel insights in the definition and treatment of high risk and oligometastatic prostate cancerFrom1 Oct 2018 → TodayFunding: FWO fellowships
- Towards a better stratification of intermediate- and high-risk non-muscle-invasive bladder cancer patientsFrom1 Sep 2016 → 1 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Role of hydroxymethylation as an epigenetic mark in prostate cancer biologyFrom1 Jan 2016 → 31 Dec 2019Funding: FWO research project
- Structural optimization of MEL-6 and development towards a prostate cancer therapeuticFrom1 Oct 2015 → 30 Sep 2017Funding: IOF - Industrial Research Fund
- Androgen Actions: from Bench to Clinic (A2B2C).From1 Oct 2014 → 30 Sep 2019Funding: BOF - Concerted Research Project from 1994
- Stem Cell and Stromal Vascular Fraction Treatment for Penile Tunica Albuginea and Urethral FibrosisFrom3 Jul 2014 → 4 Sep 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Androgen receptor functions in androgen insensitivity syndrome and prostate cancerFrom1 Aug 2013 → 2 Jun 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Study of the genetic variations in the TMPRSS2 control regions and their effects on prostate cancer development .From1 Jan 2013 → 31 Dec 2016Funding: FWO research project
Publications
1 - 10 of 442 results
- Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer(2021)
Authors: Wout Devlies, Florian Handle, Gaëtan Devos, Steven Joniau, Frank Claessens
Pages: 1 - 16 - Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction.(2021)
Authors: David Conti, Burcu F Darst, Lilit C Moss, Edward J Saunders, Xin Sheng, Alisha Chou, Fredrick R Schumacher, Ali Amin Al Olama, Sara Benlloch, Tokhir Dadaev, et al.
Pages: 65 - 75 - Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial.(2020)
Authors: Tim Eisen, Eleni Frangou, Bhavna Oza, Alastair WS Ritchie, Benjamin Smith, Rick Kaplan, Ian D Davis, Martin R Stockler, Laurence Albiges, Bernard Escudier, et al.
Pages: 4064 - 4075 - Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer(2020)
Authors: Wout Devlies, Markus Eckstein, Alessia Cimadamore, Gaëtan Devos, Lisa Moris, Thomas van den Broeck, Rodolfo Montironi, Steven Joniau, Frank Claessens, Thomas Gevaert
Number of pages: 13 - Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit(2020)
Authors: Wojciech Krajewski, Marco Moschini, Lukasz Nowak, Slawomir Poletajew, Andrzej Tukiendorf, Luca Afferi, Jeremy Teoh, Tim Muilwijk, Steven Joniau, Alessandro Tafuri, et al.
Number of pages: 12 - The Cancer of the Bladder Risk Assessment (COBRA) score for estimating cancer-specific survival after radical cystectomy: external validation in a large bi-institutional cohort(2020)
Authors: Tim Muilwijk, Murat Akand, Francesco Soria, Andrea Giordano, Uros Milenkovic, Lisa Moris, Thomas Gevaert, Hendrik Van Poppel, Maarten Albersen, Paolo Gontero, et al.
Pages: 704 - 714Number of pages: 11 - Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy(2020)
Authors: Gaëtan Devos, Charlien Berghen, Henri Van Eecke, Arthur Vander Stichele, Hendrik Van Poppel, Karolien Goffin, Cindy Mai, Liesbeth De Wever, Maarten Albersen, Wouter Everaerts, et al.
Number of pages: 14 - Reply by Authors.(2020)
Authors: Nicola Fossati, Simone Scarcella, Giorgio Gandaglia, Nazareno Suardi, Daniele Robesti, Luca Boeri, R Jeffrey Karnes, Axel Heidenreich, David Pfister, Alexander Kretschmer, et al.
Pages: 302 - Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of Ga-68-PSMA and C-11-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections(2020)
Authors: Nicola Fossati, Simone Scarcella, Giorgio Gandaglia, Nazareno Suardi, Daniele Robesti, Luca Boeri, R Jeffrey Karnes, Axel Heidenreich, David Pfister, Alexander Kretschmer, et al.
Pages: 296 - 301Number of pages: 6 - PREDICT Prostate, a useful tool in men with low- and intermediate-risk prostate cancer who are hesitant between conservative management and active treatment(2020)
Authors: Gaëtan Devos, Steven Joniau
Number of pages: 3